PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RXST vs. TRML
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


RXSTTRML
YTD Return19.07%9.85%
1Y Return101.72%77.64%
3Y Return (Ann)58.16%-26.32%
Sharpe Ratio1.731.05
Sortino Ratio2.541.65
Omega Ratio1.311.25
Calmar Ratio2.551.01
Martin Ratio6.481.77
Ulcer Index14.40%48.45%
Daily Std Dev53.95%81.53%
Max Drawdown-48.21%-94.97%
Current Drawdown-25.32%-65.21%

Fundamentals


RXSTTRML
Market Cap$1.94B$709.24M
EPS-$0.81-$1.92
Total Revenue (TTM)$138.39M$2.28M
Gross Profit (TTM)$87.81M$1.12M
EBITDA (TTM)-$34.45M-$45.79M

Correlation

-0.50.00.51.00.1

The correlation between RXST and TRML is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

RXST vs. TRML - Performance Comparison

In the year-to-date period, RXST achieves a 19.07% return, which is significantly higher than TRML's 9.85% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%50.00%100.00%JuneJulyAugustSeptemberOctoberNovember
-19.05%
98.31%
RXST
TRML

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RXST vs. TRML - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RXST
Sharpe ratio
The chart of Sharpe ratio for RXST, currently valued at 1.73, compared to the broader market-4.00-2.000.002.004.001.73
Sortino ratio
The chart of Sortino ratio for RXST, currently valued at 2.54, compared to the broader market-4.00-2.000.002.004.006.002.54
Omega ratio
The chart of Omega ratio for RXST, currently valued at 1.31, compared to the broader market0.501.001.502.001.31
Calmar ratio
The chart of Calmar ratio for RXST, currently valued at 2.55, compared to the broader market0.002.004.006.002.55
Martin ratio
The chart of Martin ratio for RXST, currently valued at 6.48, compared to the broader market0.0010.0020.0030.006.48
TRML
Sharpe ratio
The chart of Sharpe ratio for TRML, currently valued at 1.05, compared to the broader market-4.00-2.000.002.004.001.05
Sortino ratio
The chart of Sortino ratio for TRML, currently valued at 1.65, compared to the broader market-4.00-2.000.002.004.006.001.65
Omega ratio
The chart of Omega ratio for TRML, currently valued at 1.25, compared to the broader market0.501.001.502.001.25
Calmar ratio
The chart of Calmar ratio for TRML, currently valued at 1.03, compared to the broader market0.002.004.006.001.03
Martin ratio
The chart of Martin ratio for TRML, currently valued at 1.77, compared to the broader market0.0010.0020.0030.001.77

RXST vs. TRML - Sharpe Ratio Comparison

The current RXST Sharpe Ratio is 1.73, which is higher than the TRML Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of RXST and TRML, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
1.73
1.05
RXST
TRML

Dividends

RXST vs. TRML - Dividend Comparison

Neither RXST nor TRML has paid dividends to shareholders.


TTM2023
RXST
RxSight, Inc.
0.00%0.00%
TRML
Tourmaline Bio Inc.
0.00%57.75%

Drawdowns

RXST vs. TRML - Drawdown Comparison

The maximum RXST drawdown since its inception was -48.21%, smaller than the maximum TRML drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for RXST and TRML. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-25.32%
-61.91%
RXST
TRML

Volatility

RXST vs. TRML - Volatility Comparison

The current volatility for RxSight, Inc. (RXST) is 13.27%, while Tourmaline Bio Inc. (TRML) has a volatility of 16.38%. This indicates that RXST experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
13.27%
16.38%
RXST
TRML

Financials

RXST vs. TRML - Financials Comparison

This section allows you to compare key financial metrics between RxSight, Inc. and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items